Details

Lignes directrices sur les exigences relatives aux autorisations de mise en marché des vaccins contre la COVID-19 : Exigences relatives aux vaccins contre les variants du SRAS-CoV-2 - Canada.ca

Metadata and links for an archived snapshot.

Source: Health Canada
Date: Jan 5, 2026 · edition #6
Timestamp: 2026-01-05T05:32:05.234Z
Language: fr
Original URL: https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/covid19-industrie/medicaments-vaccins-traitements/ligne-directrices-autorisations-mise-marche-vaccins/exigences-matiere-essais-cliniques-autorisation.html
Replay URL: https://replay.healtharchive.ca/job-6/20260105053205/https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/covid19-industrie/medicaments-vaccins-traitements/ligne-directrices-autorisations-mise-marche-vaccins/exigences-matiere-essais-cliniques-autorisation.html#ha_snapshot=465318
ID: 465318
Status: 200
Type: text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots